US 7622118
Cancer treatment methods using selected antibodies to aminophospholipids
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 7622118 (Cancer treatment methods using selected antibodies to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 49
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62